`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`_______________
`
`
`MYLAN TECHNOLOGIES INC.,
`Petitioner
`
`v.
`
`MONOSOL RX, LLC,
`Patent Owner
`_______________
`
`Case: IPR2017-00200
`
`Patent 8,603,514
`_______________
`
`UPDATED MANDATORY NOTICES BY PATENT OWNER
`UNDER 37 CFR § 42.8
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2017-00200
`
`Pursuant to 37 C.F.R. §42.8(a)(2), MonoSol Rx, LLC (“MonoSol” or
`
`“Patent Owner”), submits the following updated mandatory notices:
`
`(1) Real Party-In-Interest – 37 CFR § 42.8(b)(1)
`
`
`
`The real party-in-interest is the Patent Owner of U.S. Patent No. 8,603,514
`
`(“the ’514 Patent”), MonoSol Rx, LLC, 30 Technology Drive, Warren, New
`
`Jersey, 07059, a Delaware limited liability company.
`
`
`
`
`
`Indivior Inc. (formerly known as Reckitt Benckiser Pharmaceuticals
`
`Inc.), 10710 Midlothian Turnpike, Suite 430, Richmond, Virginia, 23235, a
`
`Delaware corporation (“Indivior”), an exclusive licensee under the ’514 Patent, is
`
`also a real party-in-interest.
`
`
`
`(2) Related Matters – 37 CFR § 42.8(b)(2)
`
`Other than as noted below, Patent Owner is not aware of any other judicial
`
`or administrative matter (see 77 Fed. Reg. 48,576 and 48,760 (August 14, 2012))
`
`that potentially or actually, would affect, or be affected by, a decision in the
`
`proceeding herein.
`
`Case Name
`
`Dr. Reddy’s Laboratories, S.A. and Dr.
`Reddy’s Laboratories, Inc., v. MonoSol Rx,
`LLC
`Par Pharmaceutical, Inc. and IntelGenx
`Corp. v. MonoSol Rx, LLC
`Indivior Inc., et al. v. Actavis Laboratories
`UT, Inc.
`
`Case Number
`(Date Filed)
`IPR2017-01582
`(6/12/2017)
`
`IPR2017-01557
`(6/9/2017)
`1-16-cv-01009
`(10/31/2016)
`
`Court
`
`PTAB
`
`PTAB
`
`DED
`
`2
`
`
`
`
`
`
`IPR2017-00200
`
`Dr. Reddy’s Laboratories, Ltd. and Dr.
`Reddy’s Laboratories, Inc., v. MonoSol Rx,
`LLC
`Indivior Inc., Indivior UK Limited, and
`MonoSol Rx, LLC v. Teva Pharmaceuticals
`USA, Inc.
`
`Teva Pharmaceuticals USA,
`MonoSol Rx, LLC.
`
`Inc.
`
`v.
`
`Indivior Inc., Indivior UK Limited, and
`MonoSol Rx, LLC v. Sandoz Inc.
`
`Indivior Inc., Indivior UK Limited, and
`MonoSol Rx, LLC v. Mylan Technologies
`Inc., Mylan Pharmaceuticals Inc., and
`Mylan N.V.
`Indivior Inc., Indivior UK Limited, and
`MonoSol Rx, LLC v. Mylan Technologies
`Inc., Mylan Pharmaceuticals Inc., and
`Mylan N.V.
`Reckitt Benckiser Pharmaceuticals Inc., RB
`Pharmaceuticals Limited, and MonoSol Rx,
`LLC v. Alvogen Pine Brook, Inc.
`Reckitt Benckiser Pharmaceuticals Inc., RB
`Pharmaceuticals Limited, and MonoSol Rx,
`LLC v. Teva Pharmaceuticals USA, Inc.
`Reckitt Benckiser Pharmaceuticals Inc., RB
`Pharmaceuticals Limited, and MonoSol Rx,
`LLC v. Par Pharmaceutical, Inc. and
`Intelgenx Technologies Corp.
`Reckitt Benckiser Pharmaceuticals Inc., RB
`Pharmaceuticals Limited, and MonoSol Rx,
`LLC v. Alvogen Pine Brook, Inc. and
`Alvogen Group, Inc.
`
`3
`
`
`
`IPR2016-01111
`(5/31/2016)
`
`1-16-cv-00178
`(3/21/2016)
`stayed
`(5/3/2016)
`IPR2016-00281
`(12/4/2015)
`Institution Decision
`denied (5/23/2016)
`1-15-cv-01051
`(11/13/2015)
`closed
`(8/22/2016)
`1-15-cv-00209
`(11/5/2015)
`stayed
`(1/8/2016)
`1-15-cv-01016
`(11/4/2015)
`
`1-15-cv-00477
`(6/10/2015)
`
`1-14-cv-01451
`(12/2/2014)
`
`1-14-cv-00422
`(4/4/2014)
`closed
`(6/28/2016)
`1-13-cv-02003
`(12/6/2013)
`closed
`(5/9/2014)
`
`PTAB
`
`DED
`
`PTAB
`
`DED
`
`WVND
`
`DED
`
`DED
`
`DED
`
`DED
`
`DED
`
`
`
`
`
`Reckitt Benckiser Pharmaceuticals Inc., RB
`Pharmaceuticals Limited, and MonoSol Rx,
`LLC v. Watson Laboratories Inc. and
`Actavis, Inc.
`Reckitt Benckiser Pharmaceuticals, Inc.,
`RB Pharmaceuticals Ltd., and MonoSol Rx,
`LLC
`v. Par Pharmaceuticals,
`Inc.,
`Intelgenx Techs. Corp., and LTS Lohmann
`Therapy Sys. Corp.
`(3) Lead and Back-Up Counsel - 37 CFR § 42.8(b)(3)
`
`1-13-cv-01674
`(10/08/2013)
`closed
`(6/28/2016)
`1-13-cv-01461
`(8/20/2013)
`closed
`(5/27/2014)
`
`Patent Owner designates the following counsel:
`
`IPR2017-00200
`
`DED
`
`DED
`
`LEAD COUNSEL
`Harold H. Fox
`Registration No. 41,498
`STEPTOE & JOHNSON LLP
`1330 Connecticut Avenue, NW
`Washington, DC 20036-1795
`Tel: (202) 429-6284
`Fax: (202) 429-3902
`hfox@steptoe.com
`
`BACK-UP COUNSEL
`
`John L. Abramic
`
`Registration No. 51,031
`STEPTOE & JOHNSON LLP
`115 South LaSalle Street, Suite 3100
`Chicago, IL 60603
`Tel: (312) 577-1264
`Fax: (312) 577-1370
`jabramic@steptoe.com
`
`Charanjit Brahma
`Registration No. 46,574
`TROUTMAN SANDERS
`
`4
`
`
`
`
`
`
`
`
`
`
`IPR2017-00200
`
`580 California Street, Suite 1100
`San Francisco, CA 94104
`Tel: (415) 477-5713
`Fax: (415) 477-5710
`charanjit.brahma@troutmansanders.com
`
`Dustin B. Weeks
`Registration No. 67,466
`TROUTMAN SANDERS
`600 Peachtree Street, NE
`Suite 5200
`Atlanta, GA 30308
`Tel: (404) 885-3446
`Fax: (404) 962-6848
`dustin.weeks@troutmansanders.com
`
`(4) Service Information- 37 CFR § 42.8(b)(4)
`Patent Owner’s provide the following service information:
`
`Harold H. Fox
`Steptoe & Johnson LLP
`1330 Connecticut Avenue, NW
`Washington, DC 20036-1795
`Tel: (202) 429-6284
`Fax: (202) 429-3902
`hfox@steptoe.com
`514MIPR@steptoe.com
`
`Please direct all correspondence regarding this proceeding to lead counsel at
`
`hfox@steptoe.com with a copy sent to 514MIPR@steptoe.com.
`
`
`
`Date: June 29, 2017
`
`Respectfully submitted,
`
`/Harold H. Fox/
`
`
`
`
`
`5
`
`
`
`
`
`
`Steptoe & Johnson LLP
`1330 Connecticut Avenue, N.W.
`Washington, DC 20036-1795
`Telephone: (202) 429-3000
`Facsimile: (202) 429-3902
`
`IPR2017-00200
`
`Harold H. Fox
`Reg. No. 41,498
`Counsel for MonoSol Rx, LLC
`
`6
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing UPDATED
`
`MANDATORY NOTICES BY PATENT OWNER UNDER 37 CFR § 42.8 was
`served on June 29, 2017 by filing this document through the Patent Trial Appeal
`Board End to End System as well as by delivering a copy via electronic email to
`the attorneys of record for the Petitioner’s as follows:
`
`Steven W. Parmelee
`Michael T. Rosato
`Jad A. Mills
`sparmelee@wsgr.com
`mrosato@wsgr.com
`jmills@wsgr.com
`
`Daniel G. Brown
`Jonathan M.Strang
`daniel.brown@lw.com
`jonathan.strang@lw.com
`
`Ira J. Levy
`Robert V. Cerwinski
`ILevy@goodwinlaw.com
`RCerwinski@goodwinlaw.com
`
`
`June 29, 2017 By:
`
`
`
`
`/Harold H. Fox/
`
`
`
`
`
`
`
`
`
`Harold H. Fox
`Reg. No. 41,498
`STEPTOE & JOHNSON LLP
`1330 Connecticut Avenue, NW
`Washington, DC 20036-1795
`Tel: (202) 429-3000
`Fax: (202) 429-3902
`
`Counsel for MonoSol Rx, LLC
`
`
`
`